Lung Transplant Symposium
Shaf Keshavjee, MD MSc FRCSC FACS
Chief of Innovation
University Health Network, University of Toronto
Toronto, Ontario, Canada
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)